[Advances in clinical pharmacotherapy for neonatal <i>Ureaplasma urealyticum</i> infection]. [PDF]
Cai BB, Chen FF, Luo F.
europepmc +1 more source
[Progress and prospects of anti-IL-4/IL-13 monoclonal antibody treatment in chronic rhinosinusitis with nasal polyps]. [PDF]
Miao Z, Deng Y.
europepmc +1 more source
[The Clinical Application and Development of Tumor Biomarkers in China]. [PDF]
Wang C.
europepmc +1 more source
[New Landscape in the Treatment of Limited-stage Small Cell Lung Cancer: From Conventional Chemoradiotherapy to Latest Advances in Precision Medicine]. [PDF]
Han J, Dai K, Meng Z, Huang J.
europepmc +1 more source
[Association between insulin resistance and idiopathic central precocious puberty in girls and the diagnostic value of insulin resistance]. [PDF]
Li JB +8 more
europepmc +1 more source
[Analysis of Clinical Characteristics and Diagnostic Indicators in Patients With Heparin-induced Thrombocytopenia After Cardiac Surgery]. [PDF]
Wang G +10 more
europepmc +1 more source
[Nanomaterial-driven Lateral Flow Immunoassay: Technological Development and Application]. [PDF]
Zheng J, Hu X, Gu B.
europepmc +1 more source
Related searches:
背景与目的 晚期肺癌的化疗效果存在极大的个体差异,如何选择最佳化疗方案,实现肺癌化疗的个体化、效果最大化是值得探索的课题。本研究旨在检验自体积液中进行癌细胞培养及药敏试验对于合并胸腔或心包积液的肺腺癌患者优化化疗方案的临床应用价值。 方法 收集50例并发恶性胸腔和/或心包积液的肺腺癌初治患者,经闭式引流控制积液。其中25例(药敏组)于无菌条件下留取积液300 mL-500 mL,肿瘤细胞通过自体积液(xeno-free)平均11天的细胞培养而获得,继而针对8种临床常用化疗药物行药敏试验,通过CCK ...
Liang Chen +7 more
semanticscholar +1 more source

